Showing 341 - 360 results of 1,178 for search '"Genetic disorder', query time: 0.06s Refine Results
  1. 341

    Prenatal Detection of Silver–Russell Syndrome: A First Trimester Suspicion and Diagnostic Approach by Slavyana Galeva, Giuliana Diglio, Boris Stoilov, Ekaterina Uchikova, Lucian Pop

    Published 2025-01-01
    “…<i>Background and Objectives:</i> Silver–Russell Syndrome (SRS) is a rare genetic disorder characterized by prenatal and postnatal growth restriction, distinctive facial features, and body asymmetry. …”
    Get full text
    Article
  2. 342
  3. 343
  4. 344

    Image-Based Face Recognition Techniques Used in Disease Detection Approaches: A Survey by Ghalib Ahmed Salman, Inas Jawad Kadhim, Ahmed Husham Al-Badri

    Published 2024-03-01
    “…These alterations in facial patterns can serve as potential indicators for corresponding diseases, particularly in the fields of endocrinology and metabolism, Muscles-Nervous disorders, Chromosomes, and Genetic disorders, among others. …”
    Get full text
    Article
  5. 345

    Successful management of refractory epilepsy in creatine transporter deficiency with cannabidiol and clobazam: A case report by Maria Borrell‐Pichot, Carmen Fons, Susana Boronat, Alba Sierra‐Marcos

    Published 2025-02-01
    “…Plain Language Summary Creatine transporter deficiency (CRTR‐D) is a rare genetic disorder causing mental, behavioral, and movement problems. …”
    Get full text
    Article
  6. 346

    Deployment of next-generation sequencing approach for variant detection in myocardial infarction: A concise investigation by Desaraju Suresh Bhargav, Nadeem Siddiqui, Bhadra Murthy V, Vijaya Tartte, Vanaja V

    Published 2024-07-01
    “…Conclusion: To ascertain pathogenicity and role in the emergence of MI-related disorders these genes were mapped to online databases. …”
    Get full text
    Article
  7. 347

    Global prevalence of platelet-type von Willebrand disease by Omid Seidizadeh, Andrea Cairo, Maha Othman, Flora Peyvandi

    Published 2025-01-01
    “…Background: Platelet-type von Willebrand disease (PT-VWD) is a rare autosomal dominant disorder. It is caused by gain-of-function gene variants in the platelet GP1BA, which results in excessive binding between GPIbα and von Willebrand factor (VWF). …”
    Get full text
    Article
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353

    A study to identify individuals at risk to be affected by late-onset Pompe disease who had previously been given a non-specific or tentative diagnosis for their muscle weakness (Po... by Dawn A. Laney, Kayla A. Banks, Eleanor G. Botha, Maria Keever, Valynne Long, Allison L. Foley

    Published 2025-01-01
    “…Abstract Background Late-onset Pompe disease (LOPD) is an autosomal recessive lysosomal storage disorder that results in severe progressive proximal muscle weakness. …”
    Get full text
    Article
  14. 354
  15. 355

    Sequence-structure based prediction of pathogenicity for amino acid substitutions in proteins associated with primary immunodeficiencies by Ekaterina S. Porfireva, Anton D. Zadorozhny, Anastasia V. Rudik, Dmitry A. Filimonov, Alexey A. Lagunin, Alexey A. Lagunin

    Published 2025-02-01
    “…IntroductionPrimary immunodeficiencies (PIDs) are a group of rare genetic disorders characterized by dysfunction of the immune system components. …”
    Get full text
    Article
  16. 356

    How to Manage Low Estriol Levels in Pregnancies, One Center Experience by Elif YILMAZ GULEC, Alper GEZDIRICI, Akif AYAZ, Fatma Nihal OZTURK, Ibrahim POLAT

    Published 2022-03-01
    “…Objective: Low estriol (uE3) levels in the second-trimester screening for Down syndrome may be the result of fetal demise, congenital abnormalities, or some genetic hormonal disorders of the fetus. Although X-linked ichthyosis, a microdeletion syndrome with mild ichthyosis, which causes steroid sulfatase (STS) deficiency, is the most common genetic cause, second-trimester screening tests calculate the risk for a less common and severe disorder known as the Smith Lemli Opitz syndrome (SLOS). …”
    Get full text
    Article
  17. 357
  18. 358
  19. 359

    Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease... by A. A. Makarova, P. M. Melnikova, A. D. Rogachev, P. S. Demenkov, T. V. Ivanisenko, E. V. Predtechenskaya, S. Y. Karmanov, V. V. Koval, A. G. Pokrovsky, I. N. Lavrik, N. A. Kolchanov, V. A. Ivanisenko

    Published 2025-01-01
    “…Regulatory pathways to the enzymes converting significant metabolites were found from PD­specific genetic markers, VP­specific genetic markers, and the group of genetic markers common to the two diseases. …”
    Get full text
    Article
  20. 360